Recently, an interesting paper showed that the treatment with anti-PD1 antibodies led to antibody-dependent cellular phagocytosis (ADCP) which promoted the phagocytosis of the tumor cells and then the activation of AIM2 in macrophages due to the exposure of the tumor DNA. The gene discussed is AIM2; the disease is neoplasm.